Search…

Hengrui Medicine (01276.HK): HRS-2430 Injection Obtains Drug Clinical Trial Approval Notice

07/11/2025

Wisdom Financial News APP, Jiangsu Hengrui Medicine (01276.HK) announced that the company has recently received the approval and issuance of the "Drug Clinical Trial Approval Notice" from the National Medical Products Administration for HRS-2430 injection. The company will soon conduct clinical trials.

Latest

3 m ago

African stock market closing report | The South African stock market closed down 1.2%, with Naspers and Prosus falling by at least 3%.

4 m ago

Chief Financial Officer of Petrobras: The company adopts a cautious attitude towards dividends and mergers and acquisitions.

5 m ago

In early trading on Friday, Coca-Cola Company rose 1.9% in the US stock market. The company's AI-generated "Holidays are Coming" advertisement, which was praised for its creativity but also criticized for its visual defects and technical issues. Currently, the brand is promoting both the role of AI and human creativity.

7 m ago

In the early trading session on Friday in US stocks, concerns about overvaluation of artificial intelligence and weak layoff data led to a decline in tech giants. Nvidia, AMD, Microsoft, Palantir, and Tesla all fell, dragging down the Nasdaq index.

7 m ago

US stocks are moving abnormally | Crypto-related stocks continue to decline this week, Iren (IREN.US) drops more than 8%

See all latest